FDA greenlights new COVID-19 shots for this fall - Roll Call The FDA approved reformulated COVID-19 vaccines from Pfizer and Moderna, but deferred an expected authorization for Novavax’s vaccine. Roll Call · Sep 11, 2023
Updated COVID shots are coming. They're part of a trio of vaccines to block fall viruses Updated COVID-19 shots are coming soon, part of a trio of fall vaccines that doctors hope will help avoid another “tripledemic." The Independent UK · Sep 9, 2023
South Africa ‘held to ransom’ by big pharma, overcharged for COVID vaccines J&J, Pfizer charged South Africa between 15 and 33 percent more for COVID vaccine doses, contracts reveal. Al Jazeera · Sep 6, 2023
FDA's greenlighting of maternal RSV vaccine represents a major step forward in protecting young babies against the virus With the Food and Drug Administration’s Aug. 21, 2023, approval of the first vaccine against respiratory syncytial virus, or RSV, for use during late pregnancy, the U.S. will soon have a major new tool at its disposal to protect infants against the highly contagious virus. The Conversation · Aug 28, 2023
Who should get the new RSV vaccines? Here's everything you need to know There are now RSV vaccines approved for older adults and for pregnant people, and antibody shots (not vaccines) available for babies. What's the difference? LiveScience · Aug 24, 2023
FDA approves RSV vaccine for moms-to-be to guard their newborns U.S. regulators have approved the first RSV vaccine for pregnant women to protect their newborns The Independent UK · Aug 21, 2023
Pfizer's RSV vaccine to protect babies gets greenlight from FDA The Food and Drug Administration has approved the first vaccine for expectant mothers to shield their babies from RSV. WEKU · Aug 21, 2023
Covid booster jabs could go on sale privately in UK in 2024 Health officials reiterate support for private provision as lower age limit for NHS booster vaccines raised to 65 The Guardian - UK · Aug 17, 2023
Management consultants can make great CEOs—but they have to get their hands dirty first Some 47 Fortune 500 CEOs have spent time as management consultants but first took more junior roles. Fortune · Aug 16, 2023
A tsunami of AI misinformation will shape next year’s knife-edge elections If you thought social media had a hand in getting Trump elected, watch what happens when you throw AI into the mix The Guardian - UK · Aug 12, 2023
Coronavirus FAQ: Is it wiser to get a booster now or wait for the new fall booster? Maybe it's not a full-blown summer surge but COVID numbers are ticking up. For those with concerns due to personal risk factors or the start of the school year, the booster question is top of mind. WEKU · Aug 11, 2023
‘Endless possibilities’: the chemists changing molecules atom by atom A new method called ‘skeletal editing’ offers a hugely simplified way to alter matter, paving the way for world-changing innovations in personalised medicine and sustainable plastics The Guardian - UK · Aug 5, 2023
Are Pfizer (PFE) and AbbVie (ABBV) Good Value Buys for August? The pharma industry is poised to witness long-term growth with the introduction of generic medicines and growing demand for personalized and targeted treatments. Hence, fundamentally strong pharma stock AbbVie (ABBV) might be worth buying. However, it might not be the right time to invest in Pfizer (PFE). Keep reading. StockNews.com · Aug 4, 2023
Babies should get new drug that prevents RSV, CDC panel says A panel of U.S. health advisers is recommending that babies get a new drug to protect them against a respiratory virus The Independent UK · Aug 3, 2023
Zenger · Jul 30, 2023 The Most Objective Evidence Shows No Indication That Covid Vaccines Save More Lives Than They Take Medical journals describe all-cause mortality in randomized controlled trials (RCTs)
Zenger · Jul 28, 2023 FDA Violated Own Safety And Efficacy Standards In Approving Covid-19 Vaccines For Children Evidence the FDA used for those decisions violates at least three safety and efficacy standards from earlier FDA publications
WEKU · Jul 27, 2023 Tornado damage to Pfizer factory highlights vulnerabilities of drug supply A tornado that ripped through a Pfizer plant in Rocky Mount, N.C., raised worries about shortages of medicines used in hospitals. The drugs include commonly used painkillers and anesthetics.
Barchart · Jul 27, 2023 3 Sectors, 3 Unusually Active Put Options to Sell The markets have been on fire the past couple of weeks. While yesterday’s interest hike took some steam out of the markets, these three stocks and their options are unusually active and worthy of consideration.
Barchart · Jul 26, 2023 Is the Rally Getting Long in the Tooth? Try These Bear Call Spread Trades Traders should have a bearish outlook on the stock and ideally look to enter when the stock has a high implied volatility rank.
Fortune · Jul 25, 2023 Pfizer and Moderna parent are investing $100M to find the next big drug "What we are doing now, I don’t think anyone has done so far," Pfizer CEO Albert Bourla says.
The Guardian - UK · Jul 22, 2023 Revealed: drug firms funding UK patient groups that lobby for NHS approval of medicines Observer investigation shows that majority of Nice drug appraisals involve groups financially linked to maker of pharmaceuticals
The Independent UK · Jul 22, 2023 Tornado damage to Pfizer plant unlikely to cause major drug supply shortages, FDA says A tornado that tore through eastern North Carolina and struck a large Pfizer pharmaceutical plant has damaged its drug storage facility but not its medicine production areas
The Independent UK · Jul 21, 2023 NOT REAL NEWS: A look at what didn't happen this week Social media users shared a range of false claims this week
The Independent UK · Jul 20, 2023 Anti-vaxxers think God destroyed a Pfizer facility with a tornado No vaccines were produced or stored at the facility
The Independent UK · Jul 20, 2023 Tornado damage to Pfizer plant will probably create long-term shortages of some drugs hospitals need U.S. hospital drug supplies may be strained further after a tornado ripped open the roof of a Pfizer factory this week